Trade Takeda Pharmaceutical Company Limited - 4502 CFD
Add to favourite- Summary
- Historical Data
Spread | 23.70 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.011247% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.010976% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | JPY | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | Japan | ||||||||
Commission on trade | 0% |
Prev. Close | 4219.38 |
Open | 4231.35 |
1-Year Change | -3.01% |
Day's Range | 4226.17 - 4247.51 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jul 26, 2024 | 4241.92 | 20.84 | 0.49% | 4221.08 | 4251.20 | 4212.39 |
Jul 25, 2024 | 4227.46 | 30.03 | 0.72% | 4197.43 | 4237.04 | 4181.48 |
Jul 24, 2024 | 4232.14 | -22.14 | -0.52% | 4254.28 | 4265.16 | 4223.37 |
Jul 23, 2024 | 4279.82 | 41.50 | 0.98% | 4238.32 | 4284.02 | 4222.36 |
Jul 22, 2024 | 4252.99 | 16.56 | 0.39% | 4236.43 | 4253.19 | 4216.48 |
Jul 19, 2024 | 4209.11 | -27.92 | -0.66% | 4237.03 | 4238.03 | 4184.57 |
Jul 18, 2024 | 4269.85 | -0.49 | -0.01% | 4270.34 | 4305.96 | 4265.35 |
Jul 17, 2024 | 4291.79 | 54.75 | 1.29% | 4237.04 | 4294.39 | 4237.03 |
Jul 16, 2024 | 4209.99 | -20.46 | -0.48% | 4230.45 | 4239.13 | 4205.51 |
Jul 12, 2024 | 4274.93 | -8.98 | -0.21% | 4283.91 | 4331.79 | 4264.36 |
Jul 11, 2024 | 4298.78 | 36.81 | 0.86% | 4261.97 | 4305.26 | 4261.97 |
Jul 10, 2024 | 4234.04 | 7.58 | 0.18% | 4226.46 | 4243.41 | 4213.49 |
Jul 9, 2024 | 4224.07 | 36.52 | 0.87% | 4187.55 | 4240.03 | 4182.56 |
Jul 8, 2024 | 4213.69 | -14.37 | -0.34% | 4228.06 | 4242.02 | 4211.49 |
Jul 5, 2024 | 4227.46 | -5.59 | -0.13% | 4233.05 | 4252.39 | 4213.59 |
Jul 4, 2024 | 4233.05 | -3.29 | -0.08% | 4236.34 | 4240.03 | 4207.61 |
Jul 3, 2024 | 4220.08 | 1.40 | 0.03% | 4218.68 | 4228.05 | 4187.65 |
Jul 2, 2024 | 4202.12 | 15.95 | 0.38% | 4186.17 | 4210.30 | 4169.70 |
Jul 1, 2024 | 4181.28 | 13.58 | 0.33% | 4167.70 | 4193.35 | 4162.72 |
Jun 28, 2024 | 4154.25 | -11.17 | -0.27% | 4165.42 | 4183.38 | 4147.77 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Takeda Pharmaceutical Company Limited Company profile
About Takeda Pharmaceutical Co Ltd
Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.
Financial summary
BRIEF: For the nine months ended 31 December 2021, Takeda Pharmaceutical Co Ltd revenues increased 11% to Y2.696T. Net income applicable to common stockholders increased 35% to Y241.42B. Revenues reflect Intellectual Property And Service Revenue segment increase from Y69.04B to Y210.55B, Pharmaceutical Business segment increase of 5% to Y2.485T, Northern America segment increase of 9% to Y1.297T, Japan segment increase of 22% to Y530.25B.
Equity composition
FY'94-02 WAS were estimated. FY'04 Name changed from Takeda Chemical Industries, Ltd. to Takeda Pharmaceutical Company Limited. All 1&3Q, WAS were estimated and used as O/S. FY'08 Q3 WAS=O/S. FY'11 Q3 DWAS is estimated.
Industry: | Pharmaceuticals (NEC) |
4階
日本橋本町二丁目1番1号
CHUO-KU
TOKYO-TO 103-8668
JP
News
![](https://img.capital.com/imgs/articles/192x130x1/Risk-Management-in-Trading.png)
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ECB_0.png)
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024![](https://img.capital.com/imgs/articles/192x130x1/risk_2_1_optimized_450_1.png)
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024![](https://img.capital.com/imgs/articles/192x130x1/Stock-1-_1.png)
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ETF-1-_0.png)
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024![Lloyds share price forecast: An attractive dividend stock? Lloyds share price forecast: An attractive dividend stock?](https://img.capital.com/imgs/articles/192x130x1/shutterstock_536730610_0.jpg)
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024![](https://img.capital.com/imgs/articles/192x130x1/RBNZ.png)
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com